The Marijuana Herald

Oct 20 2022

Mission Green Launches Clemency Initiative to Release Parker Coleman, Serving 60 Years for Marijuana

By Anthony Martinelli in Miscellaneous

Mission Green announced today the filing of a clemency petition for Parker Coleman, Jr., who is currently serving a 60-year federal sentence for marijuana-related offenses.

This filing along with several other petitions comes on the heels of President Biden’s historic mass pardon of anyone previously convicted on a federal charge of simple possession of marijuana.

Supported by Glass House Brands, Mission Green is working with the Academy for Justice to submit clemency petitions with the hope that the President will follow through on his promise to release those convicted of non-violent marijuana offenses. The submission for Mr. Coleman is part of a new campaign, the Cannabis Clemency Initiative, that seeks to help people still incarcerated on marijuana charges, beginning with those locked up in federal prison. The Initiative brings together criminal justice scholars and reform advocates to achieve its ambitious goals.
Continue reading

Oct 20 2022

Low-Dose THC Has Positive Effect on Morbidity, Quality of Life and Mortality in Geriatric and Palliative Patients

By Anthony Martinelli in News, Studies

Low-dose THC “has a positive effect on morbidity, side effects, quality of life and mortality in geriatric and palliative patients”, according to a new study.

The study was published by the peer-reviewed journal peer-reviewed journal MMW – Fortschritte der Medizin, as well as on the website for the U.S. National Library of Medicine.

“Cannabis-containing medicines have been successfully used in our practice for more than 20 years in pain and especially in geriatric and palliative patients”, notes the abstract of the study. “While it was initially a very indication-specific use (pain, loss of appetite, etc.) and also with higher THC doses, this changed over time to low THC doses and a therapy focus on suffering-perpetuating symptoms and especially on stress (Matrix of Symptoms).”
Continue reading

Oct 20 2022

Study: THC/CBD Medications Provide Clinical Improvements to Poly Medicated Dementia Patients

By Anthony Martinelli in News, Studies

A long-term THC/CBD medication “can be administered safely and with overall positive clinical improvement to poly medicated older adults with severe dementia and associated problems.”

This is according to a new study published in the peer-reviewed journal Frontiers in Aging Neuroscience, and conducted by researchers in Switzerland.

“The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge”, according to researchers. “Short-term studies suggest an interest in the use of medical cannabis, but long-term data are lacking.”

With this in mind, the objective of this study “was to investigate the feasibility and long-term safety of administering tetrahydrocannabinol/cannabidiol (THC/CBD) treatment as an additional drug to a poly medicated population with severe dementia, evaluate clinical improvements, and collect information on the pharmacokinetics of cannabinoids and possible drug-drug interactions.”
Continue reading

Oct 19 2022

Study: “CBD Might be Beneficial in Alleviating UVB-Induced Skin Damage in Humans”

By Anthony Martinelli in News, Studies

The findings of a new study “indicate that CBD might be beneficial in alleviating UVB-induced skin damage in humans.”

The study was published in the peer-reviewed journal Molecules, and was epublished by the U.S. National Institute of Health. It was conducted by researchers at Sichuan University in China.

“Cannabidiol (CBD) has emerged as a phytocannabinoid with various beneficial effects for the skin, including anti-photoaging effects, but its mechanisms of action are not fully elucidated”, states the study’s abstract. “The study assessed CBD’s photoprotective effects against acute ultraviolet B (UVB)-induced damage in HaCaT human keratinocyte cells and murine skin tissue.”
Continue reading

Oct 19 2022

D.C. Mayor Signs Law Doubling Medical Marijuana Possession Limit Among Other Changes

By Anthony Martinelli in News

Washington D.C. Mayor Muriel Bowser has signed into law an emergency ordinance that will alter the district’s medical marijuana law.

Council Bill 240981 was signed by Mayor Bowser this week, allowing it to become law within 90 days.

In addition to increasing the possession limit for qualified medical marijuana patients from four ounces to eight, the proposal establishes “a sunset date for qualifying patients and caregivers whose registration card expired on or after March 1, 2020, to continue to purchase medicinal marijuana”.
Continue reading

Oct 18 2022

Five More States Consider Marijuana Legalization Next Month

By Anthony Martinelli in Miscellaneous

19 states have legalized marijuana for recreational use, and five more may do so next month.

On November 8th voters in five states will consider initiatives that would make marijuana legal for those 21 and older within their state’s boundaries. If all five were to pass, nearly half of the country would have legal marijuana (24 states). The five states with legalization initiatives represent around 13 million people.

The state’s considering legalization are Maryland, Arkansas, South Dakota, North Dakota and Missouri. However, it’s worth noting that although the initiatives in Maryland, Arkansas, North Dakota and Missouri would all establish legal marijuana retail outlets, South Dakota would only legalize possession, with no legal means of procuring it.
Continue reading

Oct 18 2022

Study Finds CBD May Be Effective Against Brainstem and Limbic Seizures

By Anthony Martinelli in News, Studies

A new study being published in the journal Pharmacological Reports has found that the marijuana compound cannabidiol (CBD) is effective against brainstem and limbic seizures.

“Cannabidiol (CBD) has been of rapidly growing interest in the epilepsy research field due to its antiseizure properties in preclinical models and patients with pharmacoresistant epilepsy”, states the study, which was published online ahead of print by the National Library of Medicine. “However, little is known about CBD effects in genetic models of epilepsies.”

Here researchers “assessed CBD dose-response effects in the Genetically Epilepsy Prone Rats (GEPR-3) strain, which exhibits two types of epileptic seizures, brainstem-dependent generalized tonic-clonic seizures and limbic seizures.”

Oct 18 2022

Oklahoma Governor Declares Special Election for Marijuana Legalization

By Anthony Martinelli in News

In a press release Oklahoma Governor Kevin Stitt announced a special election next year giving voters the opportunity to legalize recreational marijuana for everyone 21 and older.

Governor Stitt issued a proclamation setting the special election for March 7, 2023, at which point voters will decide the fate of State Question 820. The initiative failed to make it on the November ballot despite getting the required number of signatures signatures to do so after a delay in counting at the Secretary of State’s Office.

State Question 820 would allow those 21 and older to possess, consume, cultivate and purchase marijuana for all purposes. The possession limit would be set at one ounce of marijuana, eight grams of marijuana concentrates and eight grams of marijuana-infused products. The cultivation limit would be set at six mature plants and six seedlings.

Oct 18 2022

Report: Nearly $3 Billion in Taxes Garnered From Legal U.S. Marijuana Sales in Fiscal Year 2022

By Anthony Martinelli in News

Despite marijuana remaining illegal in many parts of the country, U.S. marijuana sales garnered $2.8 billion in taxes in fiscal year 2022.

This is according to a new report conducted by The Urban-Brookings Tax Policy Center. The report found that during the most recent full fiscal year, which ran from July 2021 to June 2022, California garnered the largest amount of marijuana taxes at $774 million. Alaska brought in the smallest amount among the legal marijuana states with $30 million.

In Colorado and Washington State, the first two states to legalize marijuana back in 2012, marijuana tax revenue now exceeds revenue for alcohol and tobacco sales.

Oct 18 2022

Study: Cannabinoids May Be Effective in Treating Hyperhidrosis

By Anthony Martinelli in News, Studies

Cannabinoids may serve as an effective treatment option for hyperhidrosis, according to a new study published by the Journal of Dermatological Treatment.

Hyperhidrosis is described by the Mayo Clinic as “abnormally excessive sweating involving the extremities, underarms, and face, usually unrelated to body temperature or exercise, and it effects about 1% of the population.

“Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities”, states the abstract for the new study. “Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis.”

New York State Launches $5 Million Grant Program to Support Retail Cannabis Entrepreneurs

Study Reveals Top U.S. Cities for Cannabis Vacations in 2025

Trulieve to Open Cannabis Dispensary in North Miami Beach on March 21, Its 163rd in Florida and 231st in the U.S.

Study: CBD May Protect Against Epilepsy-Related Neuronal Death by Blocking Toxic Astrocytes

Study: Mouthwash With CBD and Spilanthol Significantly Improves Oral Health Markers in Gingivitis Patients

Study: One-Third of Cancer Patients Report Marijuana Use, Most Discuss With Healthcare Providers

Mission Green Launches Clemency Initiative to Release Parker Coleman, Serving 60 Years for Marijuana

Mission Green announced today the filing of a clemency petition for Parker Coleman, Jr., who is currently serving a 60-year federal sentence for marijuana-related offenses.

Low-Dose THC Has Positive Effect on Morbidity, Quality of Life and Mortality in Geriatric and Palliative Patients

Low-dose THC “has a positive effect on morbidity, side effects, quality of life and mortality in geriatric and palliative patients”, according to a new study.

Study: THC/CBD Medications Provide Clinical Improvements to Poly Medicated Dementia Patients

A long-term THC/CBD medication “can be administered safely and with overall positive clinical improvement to poly medicated older adults with severe dementia and associated problems.”

Study: “CBD Might be Beneficial in Alleviating UVB-Induced Skin Damage in Humans”

The findings of a new study “indicate that CBD might be beneficial in alleviating UVB-induced skin damage in humans.”

D.C. Mayor Signs Law Doubling Medical Marijuana Possession Limit Among Other Changes

Washington D.C. Mayor Muriel Bowser has signed into law an emergency ordinance that will alter the district’s medical marijuana law.

Five More States Consider Marijuana Legalization Next Month

19 states have legalized marijuana for recreational use, and five more may do so next month.

Study Finds CBD May Be Effective Against Brainstem and Limbic Seizures

A new study being published in the journal Pharmacological Reports has found that the marijuana compound cannabidiol (CBD) is effective against brainstem and limbic seizures.

Oklahoma Governor Declares Special Election for Marijuana Legalization

In a press release Oklahoma Governor Kevin Stitt announced a special election next year giving voters the opportunity to legalize recreational marijuana for everyone 21 and older.

Report: Nearly $3 Billion in Taxes Garnered From Legal U.S. Marijuana Sales in Fiscal Year 2022

Despite marijuana remaining illegal in many parts of the country, U.S. marijuana sales garnered $2.8 billion in taxes in fiscal year 2022.

Study: Cannabinoids May Be Effective in Treating Hyperhidrosis

Cannabinoids may serve as an effective treatment option for hyperhidrosis, according to a new study published by the Journal of Dermatological Treatment.

Recent Articles

Trending Articles (past 30 days)